{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:40:32Z","timestamp":1791520832923,"version":"4.3.4"},"reference-count":26,"publisher":"The Endocrine Society","issue":"2","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["1K08DK109116"],"award-info":[{"award-number":["1K08DK109116"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL128909"],"award-info":[{"award-number":["K23HL128909"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1210\/jc.2018-01299","type":"journal-article","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T09:00:01Z","timestamp":1537088401000},"page":"487-492","source":"Crossref","is-referenced-by-count":56,"title":["Adrenal Vein Sampling Lateralization Despite Mineralocorticoid Receptor Antagonists Exposure in Primary Aldosteronism"],"prefix":"10.1210","volume":"104","author":[{"given":"Aya T","family":"Nanba","sequence":"first","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taweesak","family":"Wannachalee","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan"},{"name":"Division of Endocrinology and Metabolism, Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J","family":"Shields","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B","family":"Byrd","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E","family":"Rainey","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan"},{"name":"Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6815-6181","authenticated-orcid":false,"given":"Richard J","family":"Auchus","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan"},{"name":"Department of Pharmacology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9831-6190","authenticated-orcid":false,"given":"Adina F","family":"Turcu","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,9,14]]},"reference":[{"issue":"11","key":"key\n\t\t\t\t2019010306084151200_B1","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"9628","key":"key\n\t\t\t\t2019010306084151200_B2","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"key\n\t\t\t\t2019010306084151200_B3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"issue":"1","key":"key\n\t\t\t\t2019010306084151200_B4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"key\n\t\t\t\t2019010306084151200_B5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1530\/EJE-12-0631","article-title":"Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism","volume":"168","author":"Fourkiotis","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"key\n\t\t\t\t2019010306084151200_B6","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/jc.2013-2180","article-title":"Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases","volume":"99","author":"Iwakura","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t2019010306084151200_B7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/07853890.2013.785234","article-title":"Diagnosis and management of primary aldosteronism: an updated review","volume":"45","author":"Chao","year":"2013","journal-title":"Ann Med"},{"issue":"3","key":"key\n\t\t\t\t2019010306084151200_B8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11906-009-0038-1","article-title":"Differential diagnosis of primary aldosteronism subtypes","volume":"11","author":"Mulatero","year":"2009","journal-title":"Curr Hypertens Rep"},{"issue":"5","key":"key\n\t\t\t\t2019010306084151200_B9","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t2019010306084151200_B10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/HJH.0b013e3282f4b3e6","article-title":"Primary aldosteronism: an update on screening, diagnosis and treatment","volume":"26","author":"Rossi","year":"2008","journal-title":"J Hypertens"},{"issue":"1","key":"key\n\t\t\t\t2019010306084151200_B11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"issue":"3","key":"key\n\t\t\t\t2019010306084151200_B12","first-page":"149","article-title":"New advances in the diagnostic workup of primary aldosteronism","volume":"1","author":"Wolley","year":"2017","journal-title":"J Endocr Soc"},{"issue":"12","key":"key\n\t\t\t\t2019010306084151200_B13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1055\/s-0043-121468","article-title":"Can screening and confirmatory testing in the management of patients with primary aldosteronism be improved","volume":"49","author":"Stowasser","year":"2017","journal-title":"Horm Metab Res"},{"issue":"3","key":"key\n\t\t\t\t2019010306084151200_B14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Horm Metab Res"},{"issue":"12","key":"key\n\t\t\t\t2019010306084151200_B15","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1210\/jc.2014-2788","article-title":"Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy","volume":"99","author":"Haase","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019010306084151200_B16","unstructured":"Guidelines for ATC Classification and DDD Assignment. Oslo, Norway: Who Collaborating Centre for Drug Statistics Methodology; 2002."},{"issue":"6","key":"key\n\t\t\t\t2019010306084151200_B17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/cen.13442","article-title":"Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism","volume":"87","author":"Nanba","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"key\n\t\t\t\t2019010306084151200_B18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"key\n\t\t\t\t2019010306084151200_B19","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1210\/jc.2008-2803","article-title":"Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience","volume":"94","author":"Sukor","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t2019010306084151200_B20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome","volume":"66","author":"Young","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"14","key":"key\n\t\t\t\t2019010306084151200_B21","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary\u00a0care\u00a0practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"key\n\t\t\t\t2019010306084151200_B22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/jch.12342","article-title":"High-probability features of primary aldosteronism may obviate the need for confirmatory testing without increasing false-positive diagnoses","volume":"16","author":"Kline","year":"2014","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"4","key":"key\n\t\t\t\t2019010306084151200_B23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S2213-8587(14)70069-5","article-title":"Adrenal vein sampling in primary aldosteronism: towards a standardised protocol","volume":"3","author":"Monticone","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"key\n\t\t\t\t2019010306084151200_B24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-131-2-199907200-00005","article-title":"Medical management of aldosterone-producing adenomas","volume":"131","author":"Ghose","year":"1999","journal-title":"Ann Intern Med"},{"issue":"3","key":"key\n\t\t\t\t2019010306084151200_B25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/hr.2015.129","article-title":"Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism","volume":"39","author":"Karashima","year":"2016","journal-title":"Hypertens Res"},{"issue":"3","key":"key\n\t\t\t\t2019010306084151200_B26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1507\/endocrj.EJ15-0362","article-title":"Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism","volume":"63","author":"Matsuda","year":"2016","journal-title":"Endocr J"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/2\/487\/27374089\/jc.2018-01299.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T14:18:50Z","timestamp":1662041930000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/2\/487\/5096837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,14]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,9,14]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-01299","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,9,14]]}}}